Clinical Pharmacology of Cannabinoid Therapeutics: Drug Interactions and Side Effects
Clinical Pharmacology & Therapeutics · 2023
DOI: 10.1002/cpt.3037 ↗Kurz gefasst
Editorial in der Zeitschrift Clinical Pharmacology & Therapeutics, 2023. Verfasst von Ingolf Cascorbi. Beteiligte Einrichtung: Institute of Experimental and Clinical Pharmacology, University Hospital Schleswig-Holstein, Kiel, Germany. Hauptthemen laut MEDLINE: Cannabinoids, Drug-Related Side Effects and Adverse Reactions, Pharmacology, Pharmacology, Clinical. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 21 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute of Experimental and Clinical Pharmacology, University Hospital Schleswig-Holstein, Kiel, Germany.
ORCID-Profile: Ingolf Cascorbi
Zitieren
APA
Cascorbi, I. (2023). Clinical Pharmacology of Cannabinoid Therapeutics: Drug Interactions and Side Effects. Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt.3037
Vancouver
Cascorbi I. Clinical Pharmacology of Cannabinoid Therapeutics: Drug Interactions and Side Effects. Clinical Pharmacology & Therapeutics. 2023. doi:10.1002/cpt.3037
BibTeX
@article{Cascorbi2023,
author = {Cascorbi, Ingolf},
title = {Clinical Pharmacology of Cannabinoid Therapeutics: Drug Interactions and Side Effects},
journal = {Clinical Pharmacology & Therapeutics},
year = {2023},
doi = {10.1002/cpt.3037}
}
EUVIMED